Franz X. Schaub

1.5k total citations
23 papers, 688 citations indexed

About

Franz X. Schaub is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Franz X. Schaub has authored 23 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Franz X. Schaub's work include Cancer Genomics and Diagnostics (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (4 papers). Franz X. Schaub is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (4 papers). Franz X. Schaub collaborates with scholars based in United States, Switzerland and Germany. Franz X. Schaub's co-authors include John L. Cleveland, Radek C. Skoda, Renate Looser, Hui Hao-Shen, André Tichelli, Sai Li, Thomas Lehmann, Joanne R. Doherty, Mohammad Fallahi and Antonio L. Amelio and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Franz X. Schaub

21 papers receiving 680 citations

Peers

Countries citing papers authored by Franz X. Schaub

Since Specialization

Citations

This map shows the geographic impact of Franz X. Schaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz X. Schaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz X. Schaub more than expected).

Fields of papers citing papers by Franz X. Schaub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz X. Schaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz X. Schaub. The network helps show where Franz X. Schaub may publish in the future.

Co-authorship network of co-authors of Franz X. Schaub

This figure shows the co-authorship network connecting the top 25 collaborators of Franz X. Schaub. A scholar is included among the top collaborators of Franz X. Schaub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz X. Schaub. Franz X. Schaub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy 2022 ·Cancer Research ·Mario R. Fernandez, Franz X. Schaub, Chunying Yang, Weimin Li, Seongseok Yun, Stephanie K. Schaub, Frank C. Dorsey, Min Liu, Meredith A. Steeves, Andrea Ballabio, Alexandar Tzankov, Zhihua Chen, John M. Koomen, Anders Berglund, John L. Cleveland	9
2	Tumor-Derived Organoid Culture For Functional Personalized Oncology In Cholangiocarcinoma 2020 ·HPB ·Franz X. Schaub, (unknown), Carla Grandori, Ali Zarrinpar	1
3	BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer 2020 ·EBioMedicine ·Goldie Y.L. Lui, Reid Shaw, Franz X. Schaub, (unknown), Kay E. Gurley, (unknown), Robert L. Diaz, Rachele Rosati, (unknown), Tan A. Ince, Thomas C. Harding, Vijayakrishna K. Gadi, Barbara A. Goff, Christopher J. Kemp, Elizabeth M. Swisher, Carla Grandori	26
4	Predictive value of a CLIA-approved organoid based drug sensitivity test. 2020 ·Journal of Clinical Oncology ·(unknown), (unknown), Michael Churchill, Franz X. Schaub, Rachele Rosati, (unknown), (unknown), (unknown), (unknown), Robert L. Diaz, (unknown), Christopher J. Kemp, Vijayakrishna K. Gadi, Carla Grandori	4
5	Abstract 818: Organoid based functional test to predict personalized treatment in cholangiocarcinoma 2020 ·Cancer Research ·(unknown), Franz X. Schaub, (unknown), Michael Churchill, Rachele Rosati, (unknown), (unknown), (unknown), Robert L. Diaz, (unknown), (unknown), Ali Zarrinpar, Milind Javle, Christopher J. Kemp, (unknown), Carla Grandori	2
6	Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis 2020 ·UNC Libraries ·Weimin Li, John L. Cleveland, Md. Shamim Reza, Sany Hoxha, Franz X. Schaub, Antonio L. Amelio, (unknown), Min Guo, Colin A. Flaveny	2
7	Functional personalized oncology to determine drug sensitivity in cholangiocarcinoma. 2019 ·Journal of Clinical Oncology ·Ali Zarrinpar, (unknown), Carla Grandori, Franz X. Schaub, Rachele Rosati	0
8	Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer 2018 ·Clinical Cancer Research ·Chang Xu, Olga Nikolova, Ryan Basom, Ryan M. Mitchell, Reid Shaw, Russell Moser, (unknown), Kay E. Gurley, Michael Kao, (unknown), Franz X. Schaub, Robert L. Diaz, (unknown), In Sock Jang, Justin Guinney, Vijayakrishna K. Gadi, (unknown), Carla Grandori, Christopher J. Kemp, Eduardo Méndez	19
9	Abstract 1619: Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer 2018 ·Cancer Research ·(unknown), Rachele Rosati, (unknown), Michael Churchill, (unknown), Reid Shaw, (unknown), Robert L. Diaz, (unknown), Franz X. Schaub, Carla Grandori	3
10	Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis 2015 ·Cancer Research ·Franz X. Schaub, Md. Shamim Reza, Colin A. Flaveny, Weimin Li, (unknown), Sany Hoxha, Min Guo, John L. Cleveland, Antonio L. Amelio	92
11	Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth 2015 ·The Journal of Cell Biology ·Homa Ghalei, Franz X. Schaub, Joanne R. Doherty, Yoshihiko Noguchi, William Roush, John L. Cleveland, M. Elizabeth Stroupe, Katrin Karbstein	61
12	Myc-Directed Suppression of Autophagy Provides Therapeutic Vulnerabilities Targeting Amino Acid Homeostasis 2015 ·Blood ·Franz X. Schaub, Weimin Li, Mohammad Fallahi, Chunying Yang, Stephanie K. Schaub, Soyoung Lee, Alexandar Tzankov, Clemens A. Schmitt, Antonio L. Amelio, John L. Cleveland	2
13	Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma 2014 ·Blood ·Alexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, Sabine Steidle, Franz X. Schaub, Martina Rudelius, Iina Laitinen, Lisa M. Nilsson, Andrei Goga, Christian Peschel, Jonas A. Nilsson, John L. Cleveland, Ulrich Keller	73
14	CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB–MYC involvement 2014 ·Proceedings of the National Academy of Sciences ·Antonio L. Amelio, Mohammad Fallahi, Franz X. Schaub, Min Zhang, Mariam B. Lawani, (unknown), Mark R. Southern, Brandon Young, Lizi Wu, Maria Zajac‐Kaye, Frederic J. Kaye, John L. Cleveland, Michael D. Conkright	27
15	Organ donation: when should we consider intestinal donation 2012 ·Transplant International ·(unknown), Alfred Königsrainer, Randolph Schaffer, Franz X. Schaub, Johann Pratschke, Andreas Pascher, Wolfgang Steurer, Silvio Nadalin	15
16	Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State 2012 ·Cell ·Robert J. Rounbehler, Mohammad Fallahi, Chunying Yang, Meredith A. Steeves, Weimin Li, Joanne R. Doherty, Franz X. Schaub, Sandhya Sanduja, Dan A. Dixon, Perry J. Blackshear, John L. Cleveland	91
17	Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F 2008 ·Blood ·Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, André Tichelli, Heinz Gisslinger, Róbert Královics, Radek C. Skoda	50
18	JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis 2007 ·Haematologica ·Annette Schmitt‐Graeff, Swee‐Sen Teo, Manfred Olschewski, Franz X. Schaub, Sabine Haxelmans, A Kirn, P. Reinecke, Ulrich Germing, Radek C. Skoda	74
19	Characterization of del20q in Peripheral Blood of MPD Patients Using Copy Number Analysis and High Resolution Oligonucleotide CGH Array 2007 ·Blood ·Franz X. Schaub, Ralph Tiedt, Sylvie Hermouet, François Girodon, Róbert Královics, André Tichelli, Radek C. Skoda	2
20	[Side-effects and consequences of chronic phenacetin abuse]. 1953 ·PubMed ·Franz X. Schaub, A. Bühlmann, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact